Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $18.0600 (-0.44%) ($17.3700 - $19.2900) on Sun. Nov. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.25% (three month average) | RSI | 67 | Latest Price | $18.0600(-0.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 6% a day on average for past five trading days. | Weekly Trend | ATRA advances 10.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ATRA price | ATRA will decline at least -2.125% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.125% (StdDev 4.25%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $16.37(10.32%) | 10 Day Moving Average | $15.04(20.08%) | 20 Day Moving Average | $14.46(24.9%) | To recent high | -0.4% | To recent low | 51.5% | Market Cap | $N/A | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |